Almirall's COPD drug launches first in Denmark; UK and Germany next
This article was originally published in Scrip
Executive Summary
Almirall has launched its new chronic obstructive pulmonary disease (COPD) drug Eklirain Genuair (aclidinium) in its first market, Denmark, with further launches to follow in Germany and UK "in the coming weeks", the company said.